EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Chemokine receptors in vascular biology: a review of current evidence, implications, and therapeutic targets for hypertension

Luis Henrique Oliveira de Moraes iD, Tyler Beling, Gustavo Felix Pimenta iD, Thiago Bruder-Nascimento iD

Clinical Science · 2025

DOI: 10.1042/cs20257214 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Science, 2025. Verfasst von Luis Henrique Oliveira de Moraes und 3 weiteren Autor:innen. Beteiligte Einrichtung: Physiological Sciences, Universidade Federal de São Carlos, São Carlos, São Paulo, Brazil. Hauptthemen laut MEDLINE: Hypertension, Receptors, Chemokine, Antihypertensive Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular diseases (CVDs) remain the leading cause of death worldwide, including in the United States. Risk factors such as high cholesterol, diabetes, obesity, smoking, physical inactivity, and hypertension contribute significantly to their development. Emerging evidence highlights a central role for chemokines—small signaling molecules that guide immune cell migration to sites of infection, inflammation, or tissue damage—in the initiation and progression of hypertension. This positions chemokines and their receptors as promising pharmacological targets for blood pressure regulation and vascular protection. In this review, we explore the therapeutic potential of targeting chemokines and their receptors and summarize the main strategies reported in the literature for managing hypertension through these pathways. For this purpose, an analysis of drugs that act on the most relevant receptors at the preclinical and clinical levels was performed. After this analysis, their mechanisms of action, selectivity, and possible adverse effects were discussed. In conclusion, we reinforce that the modulation of chemokines and their receptors represents a promising approach in the control of CVDs, especially hypertension, although further clinical studies are needed to validate the efficacy and safety of this strategy, considering possible impacts on other essential immune responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionReceptors, ChemokineAntihypertensive AgentsHumansAnimalsChemokinesSignal TransductionBlood PressureMolecular Targeted Therapy

Stichwörter der Autor:innen

chemokineshypertensionvascular biology

Substanzen

Receptors, ChemokineAntihypertensive AgentsChemokines

Autor:innen und Institutionen

  • Physiological Sciences, Universidade Federal de São Carlos, São Carlos, São Paulo, Brazil.
  • Physiology and Cell Biology, Frederick P. Whiddon College of Medicine, University of South Alabama, Mobile, AL, U.S.A.
  • Department of Pharmacology, University of Sao Paulo, Sao Paulo, Brazil.

ORCID-Profile: Luis Henrique Oliveira de Moraes, Gustavo Felix Pimenta, Thiago Bruder-Nascimento

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Oliveira de Moraes, L. H., Beling, T., Felix Pimenta, G., & Bruder-Nascimento, T. (2025). Chemokine receptors in vascular biology: a review of current evidence, implications, and therapeutic targets for hypertension. Clinical Science. https://doi.org/10.1042/cs20257214

Vancouver

Oliveira de Moraes LH, Beling T, Felix Pimenta G, Bruder-Nascimento T. Chemokine receptors in vascular biology: a review of current evidence, implications, and therapeutic targets for hypertension. Clinical Science. 2025. doi:10.1042/cs20257214

BibTeX
@article{OliveiradeMoraes2025,
  author = {Oliveira de Moraes, Luis Henrique and Beling, Tyler and Felix Pimenta, Gustavo and Bruder-Nascimento, Thiago},
  title = {Chemokine receptors in vascular biology: a review of current evidence, implications, and therapeutic targets for hypertension},
  journal = {Clinical Science},
  year = {2025},
  doi = {10.1042/cs20257214}
}
Kostenlos starten →